Bishoy Michaels, DO
Pain Medicine · Dallas, TXNPI 1326570219
Payments from drug & device makers
Across 144 payments — averaging $75.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Medtronic$2K
- Boston Scientific$935
- Nevro Corp.$411
- AbbVie$273
- Relievant Medsystems, Inc.$221
- plus $844 from 15 others
What the payments were for
- Travel & lodging$5,03446%
- Food & beverage$5,80854%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 50 | $6,396 |
| Medtronic(2 entities) | 33 | $1,762 |
| Boston Scientific | 15 | $935 |
| Nevro Corp. | 9 | $411 |
| AbbVie(2 entities) | 13 | $273 |
| Relievant Medsystems, Inc. | 4 | $221 |
| Heron Therapeutics, Inc. | 2 | $159 |
| Pacira Pharmaceuticals Incorporated | 1 | $119 |
| Painteq LLC | 2 | $111 |
| SPR Therapeutics, Inc | 2 | $110 |
| GRT US Holding, Inc. | 1 | $103 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Si-bone, Inc. | 1 | $32 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Vertex | 1 | $22 |
| Scilex Pharmaceuticals Inc. | 1 | $21 |
| Globus Medical | 1 | $19 |
| Nalu Medical, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $15 |
| Foundation Fusion Solutions, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,799
- PRODIGY$1,069
- Proclaim IPG$969
- Proclaim DRG IPG$512
- WAVEWRITER ALPHA$470
- VANTA ADAPTIVESTIM$424
- Intracept$305
- INTELLIS ADAPTIVESTIM$284
- INTELLIS$133
- Senza$128
- ETERNA$125
- OCTRODE$121
- EXPAREL$119
- WaveWriter Alpha Prime 16$118
- Omnia$111
- Qutenza$103
How this compares
$10,842 in reported general payments places this provider in the 75th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 741 | $19,670 |
| Pregabalin | 141 | $2,605 |
| Gabapentin | 218 | $2,524 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 81 | $1,484 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 51 | $1,285 |
| Tramadol Hcl | 152 | $1,197 |
| Tizanidine Hcl | 48 | $506 |
| Duloxetine Hcl | 45 | $476 |
| Baclofen | 13 | $413 |
| Cyclobenzaprine Hcl | 57 | $286 |
| Oxycodone Hcl | 20 | $259 |
| Amitriptyline Hcl | 14 | $134 |
| Diazepam | 14 | $10 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Dallas
- Muhammad ZulqarnainDallas$556K
- Amol PatwardhanDallas$177K
- Justin ThompsonDallas$45K
- Demaceo HowardDallas$39K
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.